Sarepta Therapeutics Inc
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.29 | -0.52 | -2.44 | 0.15 | -0.70 | 0.85 | -5.99 | 2.45 | -0.15 | 1.25 | -1.66 | -0.05 | -0.87 | |
| 0.12 | 0.11 | 0.09 | 0.09 | 0.10 | 0.10 | 0.10 | 0.10 | 0.18 | 0.05 | 0.09 | 0.20 | 0.52 | |
| 0.54 | 0.43 | 0.41 | 0.51 | 0.43 | 0.46 | 0.43 | 0.35 | 0.15 | 0.29 | 0.24 | 0.51 | 1.22 | |
| -1.74 | -1.42 | -3.33 | -0.46 | -2.16 | -1.15 | -2.89 | 0.46 | -0.29 | 3.24 | -4.81 | -4.20 | -6.82 | |
| 0.46 | 0.18 | 0.43 | 0.29 | 0.37 | 0.35 | 0.47 | 0.30 | 0.28 | 0.06 | 0.03 | 0.03 | 0.38 | |
| -2.37 | -0.61 | 2.21 | -0.99 | -1.28 | 7.04 | -2.99 | 0.30 | 2.32 | 0.92 | -1.10 | -2.16 | -0.32 | |
| – | – | – | – | – | – | – | -0.23 | 0.00 | 0.00 | – | – | – | |
| – | – | – | – | – | – | -0.03 | 0.00 | -1.24 | -0.34 | 0.00 | 0.00 | -1.51 | |
| 0.17 | 0.02 | 0.22 | 0.40 | 0.14 | 0.45 | 0.13 | -0.22 | -1.18 | -0.37 | 0.00 | 0.00 | -1.48 | |
| -3.49 | -1.11 | -0.01 | -0.44 | -1.85 | 8.34 | -8.86 | 2.53 | 1.00 | 1.80 | -2.76 | -2.21 | -2.67 | |
| -1.75 | -0.70 | -2.87 | -0.14 | -1.07 | 0.50 | -6.46 | 2.15 | -0.43 | 1.20 | -1.69 | -0.08 | -1.25 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.